奈达铂是顺铂的衍生物,是日本开发的第二代有机铂类抗癌药,1995年在日本上市。国外临床研究显示,该药是个广谱、高效的抗癌药物,不良反应小,安全性高,无需水化,使用便利,对多种实体瘤如头颈部癌、食管癌、小细胞肺癌、非小细胞肺癌、宫颈癌、卵巢癌等有效。江苏奥赛康药业有限 Nedaplatin, a derivative of cisplatin, is the second-generation organic platinum anticancer drug developed in Japan and was marketed in Japan in 1995. Foreign clinical studies have shown that the drug is a broad spectrum of highly effective anti-cancer drugs, adverse reactions, high safety, without hydration, ease of use, a variety of solid tumors such as head and neck cancer, esophageal cancer, small cell lung cancer, Non-small cell lung cancer, cervical cancer, ovarian cancer and other effective. Jiangsu Oxycycline Pharmaceutical Limited